Adar Poonawalla, chief executive officer of Serum Institute of India

Covid-19 man­u­fac­tur­ing roundup: Co­v­ax, In­di­an man­u­fac­tur­er at odds over vac­cine sup­ply; EU plan­ning sur­plus on shot pro­duc­tion

Co­v­ax, which ships Covid-19 vac­cines to low- and mid­dle-in­come na­tions, is call­ing for more In­di­an-made dos­es of As­traZeneca’s vac­cine, Reuters re­port­ed, as a key man­u­fac­tur­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.